CrisprBits

CrisprBits is a biotechnology company leveraging CRISPR gene-editing technology to develop scalable diagnostics, therapeutics, and solutions for healthcare, food safety, environmental monitoring, and industrial applications like biofuels.

Core products and services

• CRISPR-based molecular diagnostics platform called PathCrisp for rapid, point-of-need testing of infections such as sickle cell disease, typhoid, and antimicrobial resistance.

• Gene-editing services platform named EdiCrisp using indigenous CRISPR systems for precise genome engineering, including creating disease tissue models and next-generation CAR-T cells.

• AI-augmented preclinical research platform CurieCrisp focuses on rare genetic diseases by combining patient-derived stem cells, CRISPR editing, and AI analytics.

• Strain engineering platform for industrial biotechnology applications, such as optimizing biofuel production for sustainability.

Business model and revenue streams

• Operates as a biotechnology startup providing CRISPR-based diagnostic products and gene-editing services to healthcare, research, agriculture, and bioindustrial sectors.

• Revenue comes from product sales of molecular diagnostics, contract research and development services, licensing of gene-editing technology, and partnerships for preclinical drug discovery and industrial bioengineering.

• Offers subscription and tiered pricing models for access to its platforms, with an emphasis on affordable and accessible solutions for diverse markets.